The purpose of the study is to test BGB-11417 (alone, with dexamethasone, and with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma who test positive for t(11;14). .
Active, recruiting
217-545-1946
Related Profiles
sciresearchbc@siumed.edu
Kathy Robinson